Split History
ETFs Holding THRX »    THRX Historical Stock Prices »



Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Theseus Pharmaceuticals is engaged in the discovery, development and commercialization of targeted therapies for cancer patients. Co.'s development programs are designed to address drug resistance mutations in key driver oncogenes. Co.'s product candidate, THE-630, is a pan-variant inhibitor of all main classes of activating and resistance mutations of the KIT kinase for the treatment of gastrointestinal stromal tumours. Co.'s second program is focused on inhibitors of epidermal growth factor receptor (EGFR), that are active against C797S, the common EGFR mutation that causes resistance to first- or later-line osimertinib treatment in patients with non-small cell lung cancer. According to our THRX split history records, Theseus Pharmaceuticals has had 1 split.
THRX split history picture
Theseus Pharmaceuticals (THRX) has 1 split in our THRX split history database. The split for THRX took place on June 03, 2014. This was a 1241 for 1000 split, meaning for each 1000 shares of THRX owned pre-split, the shareholder now owned 1241 shares. For example, a 1000 share position pre-split, became a 1241 share position following the split.

When a company such as Theseus Pharmaceuticals splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.

Looking at the THRX split history from start to finish, an original position size of 1000 shares would have turned into 1241 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Theseus Pharmaceuticals shares, starting with a $10,000 purchase of THRX, presented on a split-history-adjusted basis factoring in the complete THRX split history. THRX split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 10/07/2021
End date: 02/14/2024
Start price/share: $18.58
End price/share: $4.06
Dividends collected/share: $0.00
Total return: -78.15%
Average Annual Total Return: -47.56%
Starting investment: $10,000.00
Ending investment: $2,185.14
Years: 2.36
Date Ratio
06/03/20141241 for 1000
THRX is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

TLB Split History
TLGT Split History
TMO Split History
TNDM Split History
TNXP Split History
TOS Split History
TPIV Split History
TRIB Split History
TRL Split History
TRNX Split History

Email EnvelopeFree THRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

OpGen, Inc. (OPGN)
Blue Star Foods Corp. (BSFC)
Charles & Colvard, Ltd. (CTHR)
Seelos Therapeutics, Inc. (SEEL)
Chimera Investment Corporation (CIM)
Advent Technologies Holdings, Inc. (ADN)
TIAN RUIXIANG Holdings Ltd (TIRX)
Telesis Bio Inc. (TBIO)
United States Lime & Minerals, Inc. (USLM)
Inspire Veterinary Partners, Inc. (IVP)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

THRX Insider Buying

THRX Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.